Provectus Biopharmaceuticals Inc (PVCT)

[Caradoc]

A cancer cure at 2 bucks or so per share may sound fishy. It sure sounded that way to me when I first heard about PVCT last Thursday at less than $2 per share. Since then, I've done a lot of reading.

Just to get your DD started....

* Preliminary results are in for Phase 1 on breast cancer (kills cancer cells and doesn't enter or harm healthy cells) and Phase 1 on prostate cancer is about to start.
http://biz.yahoo.com/prnews/060427/sfth054.html?.v=51
and click on "initial report" at http://www.jmdutton.com/research/PVCT/index.html

* Schedule shows use of FDA's "fast track" approval process with combined Phase 2/ Phase 3 for breast cancer takes about 6 months.
http://www.knoxnews.com/kns/business/article/0,1406,KNS_376_4541948,00.html

My crystal ball sees a 10-bagger before beginning Phase 4 for breast cancer. After that, the numbers get big.

Caradoc